ReviewJournal of pregnancy2012
Prevention of preeclampsia.
Review in Journal of pregnancy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The effects of synbiotic supplementation on blood pressure and other maternal outcomes in pregnant mothers with mild preeclampsia: a triple-blinded randomized controlled trial.BMC women's health · 2024Trial
- Knowledge and attitude of pregnant women about preeclampsia in King Abdulaziz Medical City, Western Region: A cross-sectional study.PloS one · 2025Article
- Evaluating oxidative stress targeting treatments inFrontiers in cell and developmental biology · 2025Article
- Proteinuria among Pregnant Women Admitted to the Department of Obstetrics and Gynaecology of a Tertiary Care Centre.JNMA; journal of the Nepal Medical Association · 2024Article
- Small for Gestational Age Newborns in French Guiana: The Importance of Health Insurance for Prevention.International journal of public health · 2024Article
- Management and Prevention of Pre-Eclampsia in Nigeria.Healthcare (Basel, Switzerland) · 2023Article
- First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety.AJOG global reports · 2023Article
- Review
- Obstetric complications in mothers with ADHD.Frontiers in reproductive health · 2022Article
- Vascular Dysfunction in Preeclampsia.Cells · 2021Review
- Inhibiting USP14 ameliorates inflammatory responses in trophoblast cells by suppressing MAPK/NF-κB signaling.Immunity, inflammation and disease · 2021Article
- Health facility readiness and provider knowledge as correlates of adequate diagnosis and management of pre-eclampsia in Kinshasa, Democratic Republic of Congo.BMC health services research · 2020Article
- Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas.Cellular signalling · 2014Article
- Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.BioMed research international · 2014Review
- Contemporary clinical management of the cerebral complications of preeclampsia.Obstetrics and gynecology international · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preeclampsia (PE) affects around 2-5% of pregnant women. It is a major cause of maternal and perinatal morbidity and mortality. In an attempt to prevent preeclampsia, many strategies based on antenatal care, change in lifestyle, nutritional supplementation, and drugs have been studied. The aim of this paper is to review recent evidence about primary and secondary prevention of preeclampsia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.